We are live on ! Find out more
PODD icon

Insulet

386 hedge funds and large institutions have $11B invested in Insulet in 2020 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 129 increasing their positions, 136 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 36 (+3)

31% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 54

13% more call options, than puts

Call options by funds: $32.4M | Put options by funds: $28.6M

3% more funds holding

Funds holding: 376386 (+10)

3% less capital invested

Capital invested by funds: $11.4B → $11B (-$338M)

5% less repeat investments, than reductions

Existing positions increased: 129 | Existing positions reduced: 136

1.56% less ownership

Funds ownership: 107.6%106.03% (-1.6%)

Holders
386
Holders Change
+10
Holders Change %
+2.66%
% of All Funds
8.51%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.13%
New
71
Increased
129
Reduced
136
Closed
54
Calls
$32.4M
Puts
$28.6M
Net Calls
+$3.76M
Net Calls Change
-$11.3M

PODD Hedge Fund Activity: Q1 2020 in Review

386 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q1 2020, worth a combined $11B — down 3% from $11.4B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new PODD positions and 54 closed out — a net gain of 17 holders — while 129 added to existing stakes and 136 trimmed.

The largest buyer was Capital World Investors, adding an estimated $265M. The largest seller was Primecap Management, cutting an estimated $137M.

  • 386 institutional investors held Insulet (PODD) as of Q1 2020, up from 376 in Q4 2019.
  • Funds reported $11B of Insulet stock for Q1 2020, down 3% quarter-over-quarter.
  • 71 funds opened new Insulet positions in Q1 2020 and 54 closed out, a net change of +17 holders.
  • The largest Insulet buyer in Q1 2020 was Capital World Investors, an estimated $265M added.
  • The largest Insulet seller in Q1 2020 was Primecap Management, an estimated $137M sold.

Based on aggregated 13F filings for Q1 2020.